乙肝表面抗原(HBsAg)和HBsAg確證試驗(yàn)?zāi)軌蛴糜诤Y選供血人員的乙肝感染情況。

Prism系統(tǒng)是由Abbott公司(Abbott Park, Il, USA)生產(chǎn)的，以及乙肝檢測(cè)試驗(yàn)，Prism HB核心抗原最近獲得了美國食品藥品管理局的許可。其他肝炎和逆轉(zhuǎn)錄病毒檢測(cè)正在接受美國FDA的審核。

已經(jīng)在30個(gè)國家應(yīng)用，Prism系統(tǒng)將檢測(cè)整合入單個(gè)系統(tǒng)中，能夠完成許多當(dāng)前用于篩查的手工檢測(cè)。整合入系統(tǒng)中的安全措施有助于追蹤和監(jiān)測(cè)整個(gè)過程中的每一個(gè)標(biāo)本，為檢測(cè)工作人員提供質(zhì)量控制和檔案記錄。Prism系統(tǒng)每小時(shí)能夠處理160個(gè)樣本，能夠在8小時(shí)內(nèi)檢測(cè)超過1,200個(gè)樣本。
 
Automated Tests Screen Blood for Hepatitis
 
Hepatitis surface antigen (HBsAg) and HBsAg confirmatory tests are used to screen donated blood for hepatitis.

The Prism system produced by Abbott (Abbott Park, Il, USA), together with the hepatitis B test, Prism HB core, were recently cleared by the U.S. Food and Drug Administration (FDA). Additional hepatitis and retrovirus tests are currently under FDA review. Already in use in 30 countries, the Prism system consolidates testing into a single system, automating many of the manual testing procedures and steps currently used for screening blood. Safety measures built into the system help to track and monitor each sample through the testing process, providing documentation and quality control for testing facilities. The Prism system can run 160 samples per hour, making it possible to test more than 1,200 samples in an eight-hour shift.